Pfizer Ltd (PFIZ.NS) Company Profile | Reuters.com
Edition:
United States

Profile: Pfizer Ltd (PFIZ.NS)

PFIZ.NS on National Stock Exchange of India

1,849.15INR
24 Jun 2016
Change (% chg)

Rs-40.65 (-2.15%)
Prev Close
Rs1,889.80
Open
Rs1,879.00
Day's High
Rs1,879.90
Day's Low
Rs1,822.55
Volume
18,257
Avg. Vol
34,688
52-wk High
Rs2,724.90
52-wk Low
Rs1,610.10

Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company develops medicines that treat Alzheimer's disease, autism, bipolar disorder, depression, Parkinson's disease and schizophrenia, among others. The Company offers a range of products for Anti-Allergic, Anti-Diabetic, Antihistamine, Anti-Infectives, Cardiovascular, Dermatology, Erectile Dysfunction, GI, Multivitamins, Pain/Inflammation+GI, Respiratory, Urology and Vitamin/Minerals, among others. Its products include LC-OD Plus, Bidiab, Voglibose, Histizer, Isokin, Jetex Suspension, Nebasulf Ointment, Trulimax, Combantrin A, Newsta, Selsun, Agarol, Oxileptin, Ponstan, Daxid, Tricorex, Citrosoda and Cognisules, among others. It offers Patient Assistance Programmes for Glaucoma, Breast Cancer and Neuropathic Pain. The Company has manufacturing facility at Thane and Goa. The Company sells its products through independent distributors primarily in India.

Company Address

Pfizer Ltd

Pfizer Centre, 5, Patel Estate
Off S.V. Road, Jogeshwari (W)
MUMBAI     400102
P: +9122.66932000
F: +9122.66932444

Company Web Links